Kevin Soucy

Assistant Professor, Bioengineering

About

Kevin G. Soucy, Ph.D., is an Assistant Professor in the departments of Bioengineering and Cardiovascular & Thoracic Surgery at the University of Louisville (UofL).   Dr. Kevin Soucy earned his Bachelor’s degree in Mechanical Engineering from the University of New Hampshire in 2003.  He then studied Biomedical Engineering at Johns Hopkins University, receiving his Master’s degree in 2005 and his Ph.D. in 2010.  His graduate research studied the effects of aging and ionizing radiation on the vasculature, as well as potential biologic countermeasures against vascular radiation injury.  Upon completion of his graduate degrees, he joined the Bioengineering department at UofL as a Postdoctoral Associate, working with the Advanced Heart Failure Research group at the Cardiovascular Innovation Institute (CII).  In 2011, Dr. Soucy was awarded the Roger M. Prizant Research Fellowship and became full-time faculty at UofL in 2013.   Since joining UofL, Dr. Soucy has published 11 peer-reviewed journal articles and has been involved in research funded through National Institutes of Health (NIH), Kentucky Science and Technology Corporation (KSTC), American Heart Association (AHA), and industry contracts totaling over $7 million.  He is a member of prestigious organizations, such as Tau Beta Pi, AHA, the American Society of Artificial Internal Organs (ASAIO), and Biomedical Engineering Society (BMES).

TEACHING INTERESTS:

Cardiovascular physiology; Vascular biology; Biosystems Control; Biomedical devices and artificial organs

RESEARCH INTERESTS:

Dr. Soucy’s research interests include the functional alterations of the heart and vasculature in cardiovascular disease, particularly heart failure, and how mechanical circulatory support devices can be more effectively used to improve these conditions.  He also has interest in synergistic therapies to promote sustained myocardial recovery of heart failure patients.  Dr. Soucy is currently working on flow modulation of continuous flow left ventricular assist devices (LVAD) as a strategy for generating more-physiologic pulsatile flow with LVAD support and improving patient outcomes.